This Cochrane review protocol outlines a plan to evaluate whether reducing or discontinuing conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is...
Read moreDetailsThis Cochrane review protocol outlines a plan to evaluate whether reducing or discontinuing conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is...
Read moreDetailsA large Cochrane review of four randomized controlled trials involving over 42,000 pregnant women in labor evaluated whether prophylactic antibiotics...
Read moreDetailsA Cochrane review of three randomized trials involving 126 children with severe hemophilia A evaluated the benefits and harms of...
Read moreDetailsA Cochrane review of six randomized clinical trials involving 364 participants evaluated various forms of gene therapy for unresectable hepatocellular...
Read moreDetailsA comprehensive Cochrane review of 15 randomized trials involving 6109 women evaluated the clinical impact of PARP inhibitors across newly...
Read moreDetails